4 July 2019
Determined Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
schistosomiasis | 61/2019 | 62/2019 |
strongyloidiasis | 63/2019 | 64/2019 |
irritable bowel syndrome | 65/2019 | 66/2019 |
subarachnoid haemorrhage | 67/2019 | 68/2019 |
renal stone disease | 69/2019 | 70/2019 |
These SOPs revoke the SOPs previously determined for these conditions.
Determined Amendment Statements of Principles (SOPs) for:
Condition | SOPs | |
---|---|---|
aortic aneurysm and aortic wall disorders | 71/2019 | 72/2019 |
osteoarthritis | 73/2019 | 74/2019 |
morbid obesity | 75/2019 | 76/2019 |
Summary of Changes
Decided to Undertake Consultation regarding:
Condition | Reasons for Decision | Date for Final Decision |
---|---|---|
sensorineural hearing loss | Intention to remove one or more factors | October 2019 |
subdural haematoma | Intention to remove one or more factors | October 2019 |
Finalised Declarations for:
Condition | Declaration | Reasons for Decision |
---|---|---|
malignant melanoma of the skin | ||
psoriasis | ||
monoclonal gammopathy of undetermined significance (MGUS) |
Completed Investigations
The above determinations and declarations conclude the previously advertised investigations into:
- schistosomiasis
- psoriasis (focussed review - stressors (Balance of Probabilities SOP only))
- malignant melanoma of the skin (focussed - firefighting)
- morbid obesity (focussed review - definition of morbid obesity)
- osteoarthritis (focussed review - definition of osteoarthritis)
- aortic aneurysm and aortic wall disorders
- renal stone disease
- subarachnoid haemorrhage
- irritable bowel syndrome
- strongyloidiasis
- monoclonal gammopathy of undetermined significance (MGUS)